Antitumor agent-132
Antitumor agent-132 (Compound F9) is an antitumor agent. Antitumor agent-132 induces cell apoptosis and increases intracellular reactive oxygen species and reduces MMP[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Apoptosis; MMP; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-132.html
Solubility
10 mM in DMSO
Smiles
O=C1OCC2=C1CC[C@@]3(C)C2C[C@H]4[C@@]5([C@]63[C@H]([C@@H]7O[C@@]7([C@H]5OC(CCCCCCCC[N+]8=CC=C(/C=C/C9=CNC%10=CC=CC=C%109)C=C8)=O)C(C)C)O6)O4.[Br-]
Molecular Formula
C44H51BrN2O7
Molecular Weight
799.79
References & Citations
[1]Xing W, et al. Selective Antitumor Effect and Lower Toxicity of Mitochondrion-Targeting Derivatization of Triptolide. J Med Chem. 2024 Jan 3.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), CF405S conjugate, 0.1mg/mL
Human Colony Stimulating Factor Receptor, Granulocyte (GCSFR) ELISA Kit
Human Colony Stimulating Factor Receptor, Granulocyte (GCSFR) ELISA Kit
Calprotectin / MRP14 / S100A9 / Calgranulin B (rMAC3781), CF594 conjugate, 0.1mg/mL
